news-test

Top Stories of 2022: Decentralized Trials, Data Science for Trials

Dec 29, 2022, 01:00 by User Not Found

Clinical Research News | Decentralized trials have been on everyone’s lips this past year. The first real data coming in on the success and value of new trial formats has also prompted other questions around standardizing vocabulary, prioritizing the incorporation of new pharmacists, and more. In addition, new data science technologies including machine learning and “tokenization” aim to shape clinical research.
Full story
BOC Sciences Reports Its Antibody Modification and Conjugation Technologies in Detail

Dec 28, 2022, 09:26 by

The chief technician of BOC Sciences ADC development center recently reported some detailed information regarding its antibody modification and conjugation technologies, bringing the audience and customers a better understanding of how BOC Sciences has contributed to the ADC industry.
Full story
BOC Sciences Rolled Out PEG GMP Manufacture Services for Broad Applications

Dec 28, 2022, 09:26 by

BOC Sciences recently launched the PEG GMP manufacture service, a novel solution that aims at providing GMP-grade PEG products for a wide scope of applications.
Full story
Digi-Tech Pharma & AI 2023 (10 - 11 May 2023)

Dec 27, 2022, 12:03 by

Emergence of Digital Technologies in Pharmaceutical Industry” Conference, Expo
Full story
CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects

Dec 27, 2022, 12:02 by

Full story
Analyzing Protein Structures with Pronalyse’s Hydrogen Deuterium Exchange Mass Spectrometry

Dec 27, 2022, 12:02 by

Full story
Creative Proteomics Cytokine Launches Growth Factors (GF) Detection Service for Your Research

Dec 27, 2022, 11:54 by

Full story
Creative Proteomics Launches SPR-based Biacore Service to Help Study Biomolecular Interactions

Dec 27, 2022, 11:34 by

Full story
CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

Dec 27, 2022, 11:33 by

Full story
CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research

Dec 27, 2022, 11:31 by

Full story
Alfa Chemistry Commenced Offering PTFE (Polytetrafluoroethylene), Optical Fibers, and Diamond Raw Materials

Dec 27, 2022, 11:29 by

Full story
IllumiCare App Recommends Trials as Therapeutic Option, New Data Capture Interface Increases Real-World Patient Compliance, More

Dec 27, 2022, 01:00 by User Not Found

Clinical Research News | A 16-gene molecular signature investigation based on gene expression differences between patients with and without local recurrence after breast-conserving surgery; analytically sensitive infectious disease panels to support laboratory research; eClinical solutions to make clinical research processes more efficient and compliant; and more.
Full story
Creative Enzymes Offers Personalized and Customized Probiotic Blends

Dec 23, 2022, 10:41 by

Full story
Creative Enzymes Introduces Cloning Enzymes for Molecular Biology Research

Dec 23, 2022, 10:41 by

Full story
Oxygen-, Nitrogen-, Carbon-Donor Ligands for Coordination Chemistry Research

Dec 23, 2022, 10:40 by

Full story
Protection Reagents, Environmental Goods Standards, Porphyrins and Phthalocyanines

Dec 23, 2022, 10:40 by

Full story
API Supply Enriched by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban

Dec 23, 2022, 10:39 by

Full story
Wendy Buckland to Join Emmes as Chief Operating Officer

Dec 23, 2022, 10:35 by

Full story
100% Clinical Benefit Rate Achieved in Phase 1b Trial Evaluating APVO436 in Combination with Venetoclax and Azacitidine for Venetoclax Treatment Naïve Patients with Acute Myeloid Leukemia (AML)

Dec 22, 2022, 09:30 by

Aptevo's APVO436 was found to show a clinical benefit in a Phase 1 study as part of a combination therapy with venetoclax and azacitidine
Full story
Global Clinical Trials Connect 2023

Dec 22, 2022, 09:29 by

“Collaboration, Innovation and Enhancing Quality in Clinical Trials”Conference, Expo and Workshop
Full story